title: A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules.
abstract: The expected 4-week cure rate after conventional treatment of bacterial vaginosis are only 65-70%. In an attempt to improve the cure rate by adding probiotic lactobacilli we performed a double-blind placebo-controlled study of adjuvant lactobacilli treatment after an open treatment with vaginal clindamycin ovules. Women with bacterial vaginosis as defined by Amsel's criteria were treated with clindamycin ovules. Vaginal smears were collected and analysed according to Nugent's criteria. During the following menstruation period the women used, as an adjuvant treatment, either lactobacilli-prepared tampons or placebo tampons. The lactobacilli tampons were loaded with a mixture of freeze-dried L. fermentum, L. casei var. rhamnosus and L. gasseri. The cure rate was recorded after the second menstruation period. There was no improvement in the cure rate after treatment with lactobacilli-containing tampons compared to placebo tampons; the cure rates as defined by Amsel's criteria were 56% and 62%, respectively, and 55% and 63%, as defined by Nugent's criteria. This is the first study to report cure rates for women with 'intermediate' wet smear ratings according to Nugent's classification and this group had an overall cure rate of 44%. The cure rate of treatment of bacterial vaginosis was not improved by using lactobacilli-prepared tampons for one menstruation.
authors.affiliation: Department of Obstetrics and Gynecology, Alands Centralsjukhus, Finland. katarina.eriksson@ahs.aland.fi
authors.forename: Katarina
authors.initials: K
authors.lastname: Eriksson
authors.forename: Bodil
authors.initials: B
authors.lastname: Carlsson
authors.forename: Urban
authors.initials: U
authors.lastname: Forsum
authors.forename: P-G
authors.initials: PG
authors.lastname: Larsson
mesh_terms: D000282:Administration, Intravaginal; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002981:Clindamycin / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007778:Lactobacillus; D052576:Menstrual Hygiene Products / Q000382:microbiology; D008875:Middle Aged; D019936:Probiotics / Q000627:therapeutic use*; D016896:Treatment Outcome; D014626:Vaginal Smears; D016585:Vaginosis, Bacterial / Q000628:therapy*
chemical_list: D000900:Anti-Bacterial Agents; D002981:Clindamycin